Sight Sciences, Inc. (SGHT): Long-Term Debt

Annual figures by period end, from SEC filings.

$42.38M
As of 2025-12-31
+6.6%
3-year compound annual growth
2021-12-31: $35.00M2022-12-31: $35.00M2023-12-31: $35.00M2024-12-31: $40.00M2025-12-31: $42.38M$42.38M
2021-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$42.38M+5.9%2026-03-04, Balance as of period end
2024-12-31$40.00M+14.3%2025-03-07, Balance as of period end
2023-12-31$35.00M0.0%2024-03-13, Balance as of period end
2022-12-31$35.00M0.0%2023-03-16, Balance as of period end
2021-12-31$35.00Mn/a2022-03-24, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Sight Sciences, Inc. (SGHT)2025-12-31$42.38M+5.9%
PRO DEX Inc (PDEX)2026-06-30$17.51M+13.5%
TELA Bio, Inc. (TELA)2024-12-31$41.12M+1.5%
Delcath Systems, Inc. (DCTH)2024-12-31$0-100.0%
Pulmonx Corp (LUNG)2025-12-31$37.09M-0.2%
Apyx Medical Corp (APYX)2025-12-31$37.50M0.0%
Carlsmed, Inc. (CARL)2025-12-31$15.35M-0.4%
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$11.03M-50.0%
SANUWAVE Health, Inc. (SNWV)2025-12-31$21.89Mn/a

Compare SGHT, PDEX, TELA, DCTH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗